Cargando…

Identification of Pancreatic Cancer-Associated Tumor Antigen from HSP-Enriched Tumor Lysate-Pulsed Human Dendritic Cells

PURPOSE: Vaccine strategies utilizing dendritic cells (DCs) to elicit anti-tumor immunity are the subject of intense research. Although we have shown that DCs pulsed with heat-treated tumor lysate (HTL) induced more potent anti-tumor immunity than DCs pulsed with conventional tumor lysate (TL), the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Han-Soo, Kang, Dukjin, Moon, Myeong Hee, Kim, Hyung Jik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075362/ https://www.ncbi.nlm.nih.gov/pubmed/24954332 http://dx.doi.org/10.3349/ymj.2014.55.4.1014

Ejemplares similares

Immunotherapy of Malignant Melanoma with Tumor Lysate-Pulsed Autologous Monocyte-Derived Dendritic Cells
por: Kim, Dae Suk, et al.
Publicado: (2011)

Quality of tumor lysates used for pulsing dendritic cells is influenced by the method used to harvest adherent tumor cells
por: Herzog, Gloria Isabelle, et al.
Publicado: (2011)

Day-4 Myeloid Dendritic Cells Pulsed with Whole Tumor Lysate Are Highly Immunogenic and Elicit Potent Anti-Tumor Responses
por: Chiang, Cheryl Lai-Lai, et al.
Publicado: (2011)

Dendritic cells pulsed with generated tumor cell lysate from Phyllanthus amarus Schum. & Thonn. induces anti-tumor immune response
por: Mohamed, Shimaa Ibrahim Abdelmenym, et al.
Publicado: (2018)

Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination
por: Wei, Fan-Qin, et al.
Publicado: (2016)

Dataset from a proteomics analysis of tumor antigens shared between an allogenic tumor cell lysate vaccine and pancreatic tumor tissue.
por: Stingl, C., et al.
Publicado: (2022)

Mesenchymal Stromal Stem Cell-Derived Microvesicles Enhance Tumor Lysate Pulsed Dendritic Cell Stimulated Autologous T lymphocyte Cytotoxicity
por: Kukia, Nasim Rahmani, et al.
Publicado: (2018)

Autologous cervical tumor lysate pulsed dendritic cell stimulation followed by cisplatin treatment abrogates FOXP3+ cells in vitro
por: Dhandapani, Hemavathi, et al.
Publicado: (2021)

Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate
por: Chiang, Cheryl L-L, et al.
Publicado: (2011)

Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy with Cytokine-Induced Killer Cells Improves Survival in Gastric and Colorectal Cancer Patients
por: Gao, Daiqing, et al.
Publicado: (2014)

Dendritic Cells Pulsed with Tumor Lysates Induced by Tetracyanotetra(aryl)porphyrazines-Based Photodynamic Therapy Effectively Trigger Anti-Tumor Immunity in an Orthotopic Mouse Glioma Model
por: Redkin, Tikhon S., et al.
Publicado: (2023)

FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy
por: Fiammenghi, Laura, et al.
Publicado: (2010)

Novel strategy for manufacturing autologous dendritic cell/allogeneic tumor lysate vaccines for glioblastoma
por: Parney, Ian F, et al.
Publicado: (2020)

TNF-α and Tumor Lysate Promote the Maturation of Dendritic Cells for Immunotherapy for Advanced Malignant Bone and Soft Tissue Tumors
por: Miwa, Shinji, et al.
Publicado: (2012)

Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
por: TADA, FUJIMASA, et al.
Publicado: (2012)

Use of tumor cell lysate to develop peptide vaccine targeting cancer-testis antigens
por: Malhotra, Jyoti, et al.
Publicado: (2021)

Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma
por: Benitez-Ribas, Daniel, et al.
Publicado: (2018)

Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell
por: Diao, Lu, et al.
Publicado: (2023)

Correction: TNF-α and Tumor Lysate Promote the Maturation of Dendritic Cells for Immunotherapy for Advanced Malignant Bone and Soft Tissue Tumors
por: Miwa, Shinji, et al.
Publicado: (2013)

Autologous tumor lysate-loaded dendritic cell vaccination combined with Sunitinib for metastatic renal cell carcinoma
por: Kakimi, Kazuhiro, et al.
Publicado: (2014)

Plasma-Activated Medium Potentiates the Immunogenicity of Tumor Cell Lysates for Dendritic Cell-Based Cancer Vaccines
por: Tomić, Sergej, et al.
Publicado: (2021)

Whole tumor antigen vaccination using dendritic cells: Comparison of RNA electroporation and pulsing with UV-irradiated tumor cells
por: Benencia, Fabian, et al.
Publicado: (2008)

Lymph Nodes as Anti-Tumor Immunotherapeutic Tools: Intranodal-Tumor-Specific Antigen-Pulsed Dendritic Cell Vaccine Immunotherapy
por: Morisaki, Takashi, et al.
Publicado: (2022)

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity
Publicado: (1996)

Corrigendum: Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma
por: Benitez-Ribas, Daniel, et al.
Publicado: (2018)

Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine
por: Boudousquié, Caroline, et al.
Publicado: (2020)

Prominent IL-12 Production and Tumor Reduction in Athymic Nude Mice after Toxoplasma gondii Lysate Antigen Treatment
por: Pyo, Kyoung-Ho, et al.
Publicado: (2014)

Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma
por: Ribas, Antoni, et al.
Publicado: (2010)

A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
por: Kandalaft, Lana E, et al.
Publicado: (2013)

90K predicts the prognosis of glioma patients and enhances tumor lysate-pulsed DC vaccine for immunotherapy of GBM in vitro
por: Zeng, Yu, et al.
Publicado: (2021)

The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates
por: Pellegatta, Serena, et al.
Publicado: (2013)

Cytolytic Activity of Effector T-lymphocytes Against Hepatocellular Carcinoma is Improved by Dendritic Cells Pulsed with Pooled Tumor Antigens
por: Chieochansin, Thaweesak, et al.
Publicado: (2019)

Harnessing Dendritic Cells for Tumor Antigen Presentation
por: Nierkens, Stefan, et al.
Publicado: (2011)

A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma
por: Matsushita, Hirokazu, et al.
Publicado: (2014)

Activation of Cellular Players in Adaptive Immunity via Exogenous Delivery of Tumor Cell Lysates
por: Seong, Jihyun, et al.
Publicado: (2022)

Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer
por: Kandalaft, Lana E., et al.
Publicado: (2013)

Tumor cell lysate induces the immunosuppression and apoptosis of mouse immunocytes
por: DONG, BOHAN, et al.
Publicado: (2014)

Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer
por: Rojas-Sepúlveda, Daniel, et al.
Publicado: (2018)

Autologous and Pooled Tumor Lysates in Combined Immunotherapy of Patients with Glioblastoma
por: Mishinov, S.V., et al.
Publicado: (2020)

Endostatin enhances antitumor effect of tumor antigen-pulsed dendritic cell therapy in mouse xenograft model of lung carcinoma
por: Liang, Jing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1kvv48c5vamk87ep9a1o661579